摘要
目的研究血液透析患者采取丙肝及乙肝预防控制对策的医学效果。方法方便选取该院在2015年2月—2016年2月诊治的110例患有血液透析患者作为此次观察群体,并将其依据入院后挂号尾数分为参照组、探究组,各55例。其中,参照组不进行任何防御举措,而探究组则实施丙肝及乙肝的相关预防控制策略,分析与观察两组患者丙肝及乙肝的感染情况。结果经两组血透患者所采取的不同预防举措后,发现探究组乙肝感染率为1.82%,丙肝感染率3.64%;而参照组依次分别为21.81%、39.99%。两组数据对比差异有统计学意义(P<0.05)。结论对血液透析患者应用丙肝及乙肝预防控制对策,能有效降低患者发生丙肝及乙肝的感染风险,进而降低感染率,促使患者生活质量的提升,因此值得在临床中广泛推广。
Objective To research the medical effect of adopting the prevention and control measures of hepatitis B and hepatitis C of patients with hemodialysis. Methods 110 cases of patients with hemodialysis admitted and treated in our hospital from February 2015 to February 2016 were conveniently selected and divided into two groups with 55 cases in each according to the admission order, the control group did not adopt any preventive measures, while the research group adopted the hepatitis B and hepatitis C related prevention and control strategies, and the infection situations of hepatitis B and hepatitis C of the two groups were observed. Results After intervention, the differences in the infection rate of hepatitis B and hepatitis C between research group and the control group were statistically significant,(1.82%, 3.64% vs 21.81%, 39.99%)(P <0.05). Conclusion The application of hepatitis B and hepatitis C prevention and control strategies for patients with hemodialysis can effectively reduce the infection risk of patients thus reducing the infection rate and promoting the improvement of quality of life, therefore, it is worth clinical wide promotion.
作者
张玲
ZHANG Ling(Health Control Center, Rizhao Gangkou Hospital, Rizhao, Shandong Province, 276826 Chin)
出处
《中外医疗》
2017年第11期21-23,共3页
China & Foreign Medical Treatment
关键词
血液透析
丙肝
乙肝
Hemodialysis
Hepatitis C
Hepatitis B
